annual current liabilities:
$3.56B+$17.20M(+0.48%)Summary
- As of today (May 21, 2025), VRTX annual total current liabilities is $3.56 billion, with the most recent change of +$17.20 million (+0.48%) on December 31, 2024.
- During the last 3 years, VRTX annual current liabilities has risen by +$1.42 billion (+66.41%).
- VRTX annual current liabilities is now at all-time high.
Performance
VRTX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$3.78B+$218.60M(+6.13%)Summary
- As of today (May 21, 2025), VRTX quarterly total current liabilities is $3.78 billion, with the most recent change of +$218.60 million (+6.13%) on March 31, 2025.
- Over the past year, VRTX quarterly current liabilities has dropped by -$12.70 million (-0.33%).
- VRTX quarterly current liabilities is now -4.78% below its all-time high of $3.97 billion, reached on September 30, 2024.
Performance
VRTX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VRTX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.5% | -0.3% |
| 3 y3 years | +66.4% | +73.5% |
| 5 y5 years | +167.1% | +145.9% |
VRTX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.4% | -4.8% | +73.5% |
| 5 y | 5-year | at high | +167.1% | -4.8% | +145.9% |
| alltime | all time | at high | >+9999.0% | -4.8% | >+9999.0% |
VRTX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $3.78B(+6.1%) |
| Dec 2024 | $3.56B(+0.5%) | $3.56B(-10.3%) |
| Sep 2024 | - | $3.97B(+12.0%) |
| Jun 2024 | - | $3.55B(-6.6%) |
| Mar 2024 | - | $3.80B(+7.0%) |
| Dec 2023 | $3.55B(+29.4%) | $3.55B(-1.4%) |
| Sep 2023 | - | $3.60B(+7.4%) |
| Jun 2023 | - | $3.35B(+10.8%) |
| Mar 2023 | - | $3.03B(+10.4%) |
| Dec 2022 | $2.74B(+28.0%) | $2.74B(+5.1%) |
| Sep 2022 | - | $2.61B(+2.1%) |
| Jun 2022 | - | $2.56B(+17.2%) |
| Mar 2022 | - | $2.18B(+1.8%) |
| Dec 2021 | $2.14B(+14.1%) | $2.14B(+11.9%) |
| Sep 2021 | - | $1.91B(+4.2%) |
| Jun 2021 | - | $1.84B(-5.5%) |
| Mar 2021 | - | $1.94B(+3.5%) |
| Dec 2020 | $1.88B(+40.7%) | $1.88B(-6.3%) |
| Sep 2020 | - | $2.00B(+11.4%) |
| Jun 2020 | - | $1.80B(+16.9%) |
| Mar 2020 | - | $1.54B(+15.3%) |
| Dec 2019 | $1.33B(+19.1%) | $1.33B(-3.9%) |
| Sep 2019 | - | $1.39B(+10.3%) |
| Jun 2019 | - | $1.26B(+13.8%) |
| Mar 2019 | - | $1.11B(-1.2%) |
| Dec 2018 | $1.12B(+38.8%) | $1.12B(+12.9%) |
| Sep 2018 | - | $992.51M(+7.0%) |
| Jun 2018 | - | $927.30M(+12.1%) |
| Mar 2018 | - | $827.31M(+2.5%) |
| Dec 2017 | $807.26M(+1.9%) | $807.26M(+13.6%) |
| Sep 2017 | - | $710.74M(+13.6%) |
| Jun 2017 | - | $625.41M(+27.7%) |
| Mar 2017 | - | $489.80M(-38.2%) |
| Dec 2016 | $792.54M(+56.6%) | $792.54M(+9.6%) |
| Sep 2016 | - | $722.84M(+16.1%) |
| Jun 2016 | - | $622.86M(+12.8%) |
| Mar 2016 | - | $552.04M(+9.1%) |
| Dec 2015 | $506.17M(+37.5%) | $506.17M(+35.0%) |
| Sep 2015 | - | $374.96M(+0.3%) |
| Jun 2015 | - | $373.82M(+23.6%) |
| Mar 2015 | - | $302.44M(-17.9%) |
| Dec 2014 | $368.25M(-7.4%) | $368.25M(-1.1%) |
| Sep 2014 | - | $372.18M(+2.5%) |
| Jun 2014 | - | $362.97M(-2.8%) |
| Mar 2014 | - | $373.50M(-6.1%) |
| Dec 2013 | $397.83M(-8.0%) | $397.83M(-2.8%) |
| Sep 2013 | - | $409.50M(+7.3%) |
| Jun 2013 | - | $381.65M(-6.4%) |
| Mar 2013 | - | $407.64M(-5.8%) |
| Dec 2012 | $432.62M(+10.3%) | $432.62M(+6.4%) |
| Sep 2012 | - | $406.73M(+7.1%) |
| Jun 2012 | - | $379.71M(+6.4%) |
| Mar 2012 | - | $356.81M(-9.1%) |
| Dec 2011 | $392.35M(-17.4%) | $392.35M(-28.5%) |
| Sep 2011 | - | $548.95M(+14.6%) |
| Jun 2011 | - | $478.97M(+15.1%) |
| Mar 2011 | - | $416.19M(-12.3%) |
| Dec 2010 | $474.78M(+66.7%) | $474.78M(+52.4%) |
| Sep 2010 | - | $311.57M(+6.6%) |
| Jun 2010 | - | $292.38M(+38.2%) |
| Mar 2010 | - | $211.54M(-25.7%) |
| Dec 2009 | $284.88M(+31.5%) | $284.88M(+23.1%) |
| Sep 2009 | - | $231.37M(+26.0%) |
| Jun 2009 | - | $183.68M(+2.4%) |
| Mar 2009 | - | $179.30M(-17.2%) |
| Dec 2008 | $216.56M | $216.56M(+20.0%) |
| Sep 2008 | - | $180.46M(-1.3%) |
| Jun 2008 | - | $182.89M(+5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $173.32M(-13.0%) |
| Dec 2007 | $199.28M(-20.6%) | $199.28M(+7.3%) |
| Sep 2007 | - | $185.71M(-8.5%) |
| Jun 2007 | - | $202.90M(+16.2%) |
| Mar 2007 | - | $174.59M(-30.4%) |
| Dec 2006 | $251.01M(+150.4%) | $251.01M(+55.5%) |
| Sep 2006 | - | $161.46M(+48.5%) |
| Jun 2006 | - | $108.73M(+32.2%) |
| Mar 2006 | - | $82.24M(-18.0%) |
| Dec 2005 | $100.24M(-34.8%) | $100.24M(-17.7%) |
| Sep 2005 | - | $121.81M(-11.7%) |
| Jun 2005 | - | $137.99M(-6.9%) |
| Mar 2005 | - | $148.17M(-3.6%) |
| Dec 2004 | $153.75M(+10.6%) | $153.75M(+14.4%) |
| Sep 2004 | - | $134.45M(-2.2%) |
| Jun 2004 | - | $137.45M(+13.7%) |
| Mar 2004 | - | $120.84M(-13.1%) |
| Dec 2003 | $139.07M(+115.3%) | $139.07M(+16.1%) |
| Sep 2003 | - | $119.83M(+38.5%) |
| Jun 2003 | - | $86.52M(+53.7%) |
| Mar 2003 | - | $56.29M(-12.9%) |
| Dec 2002 | $64.60M(-29.4%) | $64.60M(+9.9%) |
| Sep 2002 | - | $58.79M(-5.6%) |
| Jun 2002 | - | $62.29M(-5.0%) |
| Mar 2002 | - | $65.55M(-28.4%) |
| Dec 2001 | $91.55M(+31.1%) | $91.55M(-0.4%) |
| Sep 2001 | - | $91.90M(+136.5%) |
| Jun 2001 | - | $38.85M(+21.9%) |
| Mar 2001 | - | $31.87M(-54.4%) |
| Dec 2000 | $69.86M(+277.2%) | $69.86M(-65.0%) |
| Sep 2000 | - | $199.84M(+712.6%) |
| Jun 2000 | - | $24.59M(+53.3%) |
| Mar 2000 | - | $16.04M(-13.4%) |
| Dec 1999 | $18.52M(+41.4%) | $18.52M(+41.4%) |
| Sep 1999 | - | $13.10M(-7.7%) |
| Jun 1999 | - | $14.20M(+2.9%) |
| Mar 1999 | - | $13.80M(+5.3%) |
| Dec 1998 | $13.10M(-4.4%) | $13.10M(+17.0%) |
| Sep 1998 | - | $11.20M(+28.7%) |
| Jun 1998 | - | $8.70M(0.0%) |
| Mar 1998 | - | $8.70M(-36.5%) |
| Dec 1997 | $13.70M(+93.0%) | $13.70M(+16.1%) |
| Sep 1997 | - | $11.80M(+26.9%) |
| Jun 1997 | - | $9.30M(+2.2%) |
| Mar 1997 | - | $9.10M(+28.2%) |
| Dec 1996 | $7.10M(-19.3%) | $7.10M(+31.5%) |
| Sep 1996 | - | $5.40M(-28.0%) |
| Jun 1996 | - | $7.50M(0.0%) |
| Mar 1996 | - | $7.50M(-14.8%) |
| Dec 1995 | $8.80M(+46.7%) | $8.80M(+12.8%) |
| Sep 1995 | - | $7.80M(-10.3%) |
| Jun 1995 | - | $8.70M(+47.5%) |
| Mar 1995 | - | $5.90M(-1.7%) |
| Dec 1994 | $6.00M(-17.8%) | $6.00M(-18.9%) |
| Sep 1994 | - | $7.40M(+7.2%) |
| Jun 1994 | - | $6.90M(+23.2%) |
| Mar 1994 | - | $5.60M(-23.3%) |
| Dec 1993 | $7.30M(+87.2%) | $7.30M(+17.7%) |
| Sep 1993 | - | $6.20M(+34.8%) |
| Jun 1993 | - | $4.60M(-2.1%) |
| Mar 1993 | - | $4.70M(+20.5%) |
| Dec 1992 | $3.90M(+44.4%) | $3.90M(+21.9%) |
| Sep 1992 | - | $3.20M(+10.3%) |
| Jun 1992 | - | $2.90M(+11.5%) |
| Mar 1992 | - | $2.60M(-3.7%) |
| Dec 1991 | $2.70M(+68.8%) | $2.70M(+17.4%) |
| Sep 1991 | - | $2.30M(+4.5%) |
| Jun 1991 | - | $2.20M(+37.5%) |
| Dec 1990 | $1.60M | $1.60M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total current liabilities?
- What is the all time high annual current liabilities for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual current liabilities year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly current liabilities year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total current liabilities?
The current annual current liabilities of VRTX is $3.56B
What is the all time high annual current liabilities for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total current liabilities is $3.56B
What is Vertex Pharmaceuticals Incorporated annual current liabilities year-on-year change?
Over the past year, VRTX annual total current liabilities has changed by +$17.20M (+0.48%)
What is Vertex Pharmaceuticals Incorporated quarterly total current liabilities?
The current quarterly current liabilities of VRTX is $3.78B
What is the all time high quarterly current liabilities for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total current liabilities is $3.97B
What is Vertex Pharmaceuticals Incorporated quarterly current liabilities year-on-year change?
Over the past year, VRTX quarterly total current liabilities has changed by -$12.70M (-0.33%)